You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
|
---|---|
Published in |
BMC Infectious Diseases, January 2014
|
DOI | 10.1186/1471-2334-14-14 |
Pubmed ID | |
Authors |
Fern Terris-Prestholt, Anna M Foss, Andrew P Cox, Lori Heise, Gesine Meyer-Rath, Sinead Delany-Moretlwe, Thomas Mertenskoetter, Helen Rees, Peter Vickerman, Charlotte H Watts |
Abstract |
There is urgent need for effective HIV prevention methods that women can initiate. The CAPRISA 004 trial showed that a tenofovir-based vaginal microbicide had significant impact on HIV incidence among women. This study uses the trial findings to estimate the population-level impact of the gel on HIV and HSV-2 transmission, and price thresholds at which widespread product introduction would be as cost-effective as male circumcision in urban South Africa. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | 25% |
United States | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 98 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 20 | 20% |
Researcher | 16 | 16% |
Student > Ph. D. Student | 9 | 9% |
Student > Postgraduate | 8 | 8% |
Student > Doctoral Student | 6 | 6% |
Other | 21 | 21% |
Unknown | 20 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 21% |
Social Sciences | 15 | 15% |
Nursing and Health Professions | 12 | 12% |
Economics, Econometrics and Finance | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Other | 13 | 13% |
Unknown | 26 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2014.
All research outputs
#13,325,144
of 22,739,983 outputs
Outputs from BMC Infectious Diseases
#3,275
of 7,663 outputs
Outputs of similar age
#161,737
of 304,788 outputs
Outputs of similar age from BMC Infectious Diseases
#57
of 136 outputs
Altmetric has tracked 22,739,983 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,663 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,788 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 136 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.